Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 325411 Medicinal & Botanical Manufacturing |
Address | 1100 Island Drive Suite 203 Redwood City, CA 94065 |
Kriya Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $100 - $500 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Kriya Therapeutics P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
KRIYA ONCOLOGY Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders | 01/11/2022 |
KRIYA RARE DISEASE Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders | 01/11/2022 |
KRIYA CHRONIC DISEASE Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders | 01/11/2022 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
XYMOGEN | Orlando, FL | 100 |
AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
NUTRITION FORMULATORS | Miramar, FL | 36 |
RTPR | Cabot, AR | 33 |
INTEGRATED BOTANICS | Fort Worth, TX | 29 |
COSMAX NBT USA | Garland, TX | 29 |
CJB INDUSTRIES | Valdosta, GA | 28 |
ALTERNATIVE LABORATORIES | Naples, FL | 28 |
S&B PHARMA | Azusa, CA | 28 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
GENENTECH | South San Francisco, CA | 100 |
IGM BIOSCIENCES | Mountain View, CA | 1 |
AKASA | South San Francisco, CA | 1 |
MYOKARDIA | South San Francisco, CA | 1 |
KRIYA THERAPEUTICS | Redwood City, CA | 1 |
EPICRISPR BIOTECHNOLOGIES | South San Francisco, CA | 1 |
Company | Revenue ($ MM) |
---|---|
|